| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8232208 | International Journal of Radiation Oncology*Biology*Physics | 2010 | 6 Pages |
Abstract
Lipoplatin radio-chemotherapy is feasible, with minor hematological and nonhematological toxicity. The high complete response rates obtained support the testing of Lipoplatin in the adjuvant postoperative or preoperative radio-chemotherapy setting for the treatment of gastric cancer.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Michael I. M.D., Alexandra M.D., Michael M.D., George M.D., Pelagia M.D., Ioannis Ph.D., Marianthi M.D., Kyriaki M.Sc., Efthimios M.D., Teni M.D.,